Vinay Prasad Md Mph
@vprasadmdmph·195K subscribers·579 videos
3.48 The Predictive Value of High Tumor Mutational Burden with Dr. Luc Morris
Posted
April 1, 2021
Views
360
Likes
10
Comments
1
Engagement
April 1, 2021
360
10
1
3.06%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:01:30Now PlayingToday we interview Dr. Luc Morris of Memorial Sloan Kettering Cancer Center on his new paper out now in JAMA Oncology titled "Response Rates to Anti-PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase".
Response Rates: doi.org/10.1001/jamaoncol.2020.7684
Back us on Patreon! www.patreon.com/plenarysession
Vinay Prasad, MD MPH
HemeOnc Doctor & Associate Professor of Epi/ Biostats
Host of Plenary Session Podcast
Twitter @vprasadmdmph
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
